2018 years 4 month 18 day, United States International Trade Commission (ITC) Vote on specific praseodymium bromide and products containing that substance (CERTAIN CLIDINIUM BROMIDE AND PRODUCTS CONTAINING SAME) start 337 investigation (Survey coding: 337-TA-1109) .

2018 years 2 month 20 day, United States Valeant Pharmaceuticals North America LLC of Bridgewater, NJ, Canada Valeant Pharmaceuticals International, Inc. , of Quebec, Canada To the United States ITC Put forward 337 Application for initiation of investigation, Advocate exports to the United States, The product is imported and sold in the United States using false or misleading advertising (marketed using false or misleading advertisingconcerning the FDA approval status of the imported products) , Request the United States ITC Issue a general exclusion order, Limited exclusion order, injunction.

The United States International Trade Commission finally put the United States Bi-Coastal Pharma International LLC of Shrewsbury, NJ, United States Bi-Coastal Pharmaceutical Corporation ofShrewsbury, NJ, United States ECI Pharmaceuticals LLC of Fort Lauderdale, FL, United States Virtus Pharmaceuticals LLC of Tampa, FL, United States Virtus Pharmaceuticals OPCO II LLC of Nashville, TN Listed as a designated respondent.

The US Trade Commission will file a case 45 The investigation will be completed within days. Except when the United States Trade Representative vetoes for policy reasons, The United States International Trade Commission 337 The order of relief issued in the case shall take effect on the date of issuance and shall be issued on the first day after the date of issuance 60 The date shall be final.

(Compiled from: United States International Trade Commission website)

(Reprinted from China Intellectual Property Network   in　Juan compilation)

Original text:

https: //www. usitc. gov/secretary/fed_reg_notices/337/337_1109_notice_04182018sgl. pdf

https: //www. usitc. gov/press_room/news_release/2018/er0418ll935. htm

disclaimer: This website reprint articles are from the Internet, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact this website, This website will be corrected in due course, delete, thank you.